Kylie O’Keefe

Chief Strategy Officer

Kylie O’Keefe brings more than 20 years of diverse pharmaceutical industry experience to her role as Chief Strategy Officer at PTC. In this role, she has global leadership of PTC products from pipeline to launch. In addition, she leads the Business Development and Investor Relations departments.

Kylie has extensive experience in leading global, regional, and local cross-functional teams, assets and brands across the full drug development pathway. She is recognized as an entrepreneurial innovator with the ability to drive change and transform vision into results. Kylie is also an effective communicator and leader, creating collaborative and dynamic working environments within global cultures.

Prior to joining PTC, Kylie began her career in the laboratory before joining Peplin, a biotechnology company, where she held key roles in Clinical Development. She then moved to LEO Pharma where she held various commercial roles including leadership positions in Global and US Strategic Marketing and Global Business and Launch Planning.

Kylie studied Biotechnology Innovation at Queensland University of Technology in Australia.